Genocea Biosciences logo

Genocea Biosciences

A biopharmaceutical company developing T cell vaccines and immunotherapies

4

Funding Rounds

$145.3m

Money raised

Overview

A biopharmaceutical company developing T cell vaccines and immunotherapies

Funding

Funding series

Funding Series Analysis

The company Genocea Biosciences has raised a total of $65.4m in funding over 4 rounds.

Key Insights:

  • Genocea Biosciences seed round: $400k
  • Genocea Biosciences Series C round: $30m
  • Genocea Biosciences Series B round: $35m
  • GENOCEA BIOSCIENCES, INC. funding round, July 2020: $79.88m
Genocea Biosciences logo
Genocea Biosciences seed round $400k
Genocea Biosciences logo
Genocea Biosciences Series C round $30m
Genocea Biosciences logo
Genocea Biosciences Series B round $35m
Genocea Biosciences logo
GENOCEA BIOSCIENCES, INC. funding round, July 2020 $79.88m

Industries

Genocea Biosciences is active in the following industries:
  • Internal medicine
  • Immunotherapy
  • Therapeutics
  • Cancer immunotherapy
  • Oncology
  • Biopharmaceutical
  • Therapy
  • Vaccine
  • Biomedical engineering
  • Technology
  • Cancer
  • Biology
  • Biotechnology
  • Healthcare
  • Medicine
  • Engineering
  • Casino